推荐产品
形狀
liquid
品質等級
包含
10 % (v/v) methanol
技術
HPLC: suitable
密度
1.269 g/mL at 25 °C
應用
food and beverages
SMILES 字串
ClCCl
InChI
1S/CH2Cl2/c2-1-3/h1H2
InChI 密鑰
YMWUJEATGCHHMB-UHFFFAOYSA-N
正在寻找类似产品? 访问 产品对比指南
一般說明
The product is a 10%v/v solution of dichloromethane in methanol. Dichloromethane (DCM) is a chlorinated organic solvent that has C2V symmetry, low boiling point, high density and is immiscible in water. A study reports the dielectric characteristics of DCM over a wide frequency range.
訊號詞
Warning
危險分類
Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 2 - STOT SE 3
標靶器官
Central nervous system
儲存類別代碼
6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects
水污染物質分類（WGK）
WGK 2
Broadband dielectric response of dichloromethane.
Hunger J, et al.
Chemical Physics Letters, 471(1), 85-91 (2009)
Aria Nouri et al.
Spine, 40(14), 1092-1100 (2015-04-22)
Ambispective study. To determine whether MRI parameters improve the predictive performance of a validated clinical prediction rule used to assess functional outcomes in surgical patients with DCM. Degenerative cervical myelopathy (DCM) is the most common cause of spinal cord dysfunction
Damian M Herz et al.
Brain : a journal of neurology, 138(Pt 6), 1658-1666 (2015-04-18)
Dopaminergic signalling in the striatum contributes to reinforcement of actions and motivational enhancement of motor vigour. Parkinson's disease leads to progressive dopaminergic denervation of the striatum, impairing the function of cortico-basal ganglia networks. While levodopa therapy alleviates basal ganglia dysfunction
Molamma P Prabhakaran et al.
Materials science & engineering. C, Materials for biological applications, 56, 66-73 (2015-08-08)
Advanced engineering of materials for the development of drug delivery devices provides scope for novel and versatile strategies for treatment of various diseases. 'Electrospraying' was used to prepare PLGA microparticles and further encapsulate the drug, metronidazole (Met) within the particles
Myat Noe Hsu et al.
Biomicrofluidics, 9(5), 052601-052601 (2015-04-01)
The poor solubility of many newly discovered drugs has resulted in numerous challenges for the time-controlled release of therapeutics. In this study, an advanced drug delivery platform to encapsulate and deliver hydrophobic drugs, consisting of poly (lactic-co-glycolic acid) (PLGA) nanoparticles
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门